Top After-Market NASDAQ Losers (MMYT, TSTC, TTEK, TIVO, NHWK)
The top after-market NASDAQ stock market losers are: MakeMyTrip, Telestone Technologies, Tetra Tech, TiVo, NightHawk Radiology Holdings, Ebix, Globe Specialty Metals, The Hain Celestial Group, A123 Systems, and Ariad Pharmaceuticals.
MakeMyTrip Ltd. (MMYT) lost 4.08 percent to $27.51 in the after-hours trading.
Telestone Technologies Corp. (TSTC) plunged 3.75 percent to $13.60 in the after-market session.
Tetra Tech Inc. (TTEK) plummeted 3.15 percent to $22.13 in the after-hours trading.
TiVo Inc. (TIVO) fell 2.84 percent to $8.56 in the after-market session. The company's third quarter loss widened to $21 million or 18 cents a share from $6.4 million or 6 cents a share last year. Revenue declined to $50.8 million from $57.1 million. Analysts had expected a loss of 17 cents a share on revenue of $41.41 million. TiVo expects fourth quarter net loss of $32 million to $34 million and service and technology revenues of $40 million to $42 million.
NightHawk Radiology Holdings, Inc. (NHWK) dropped 2.48 percent to $6.28 in the after-hours trading.
Ebix Inc. (EBIX) tumbled 2.31 percent to $20.68 in the after-market session.
Globe Specialty Metals, Inc. (GSM) declined 2.25 percent to $16.06 in the after-hours trading. The company said in a regulatory filing that it will establish a nominating committee composed entirely of independent directors at the next regular meeting of its board. The company has also amended its 2006 employee, director and consultant stock plan.
Hain Celestial Group, Inc. (HAIN) decreased 1.68 percent to $25.74 in the after-market session.
A123 Systems, Inc. (AONE) moved down 1.44 percent to $8.87 in the after-hours trading. The company said its chief financial officer and vice president of finance & administration, Michael Rubino, will be leaving the company effective Jan. 14, 2011. A123 said it has initiated a search for Rubino's successor.
Ariad Pharmaceuticals Inc. (ARIA) fell 1.38 percent to $3.78 in the after-market session.
© Copyright IBTimes 2024. All rights reserved.